| 0 |
ANAESTHETIC COMPLICATION |
380 |
0.1414 |
| 1 |
ARACHNOID WEB |
1 |
0.0714 |
| 2 |
PNEUMORRHACHIS |
1 |
0.0476 |
| 3 |
ACUTE MACULAR NEURORETINOPATHY |
6 |
0.0351 |
| 4 |
CONUS MEDULLARIS SYNDROME |
1 |
0.0154 |
| 5 |
BROWN-SEQUARD SYNDROME |
1 |
0.0147 |
| 6 |
VENOUS PRESSURE INCREASED |
1 |
0.0135 |
| 7 |
PURTSCHER RETINOPATHY |
1 |
0.0122 |
| 8 |
SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE |
1 |
0.0119 |
| 9 |
PENILE NECROSIS |
1 |
0.0090 |
| 10 |
PERIPARTUM CARDIOMYOPATHY |
1 |
0.0058 |
| 11 |
PITUITARY APOPLEXY |
1 |
0.0057 |
| 12 |
MENINGITIS CHEMICAL |
1 |
0.0045 |
| 13 |
BRACHIAL PLEXOPATHY |
1 |
0.0045 |
| 14 |
MATERNAL EXPOSURE DURING DELIVERY |
4 |
0.0040 |
| 15 |
SPINAL CORD INJURY CERVICAL |
1 |
0.0040 |
| 16 |
UTERINE HYPERTONUS |
1 |
0.0037 |
| 17 |
PUPILLARY LIGHT REFLEX TESTS ABNORMAL |
1 |
0.0032 |
| 18 |
ANAESTHESIA |
1 |
0.0027 |
| 19 |
SPINAL CORD HAEMORRHAGE |
1 |
0.0025 |
| 20 |
PROCEDURAL HEADACHE |
1 |
0.0024 |
| 21 |
BRADYCARDIA FOETAL |
2 |
0.0024 |
| 22 |
GENERAL ANAESTHESIA |
1 |
0.0022 |
| 23 |
MYELITIS TRANSVERSE |
3 |
0.0021 |
| 24 |
MYOPATHY TOXIC |
1 |
0.0016 |
| 25 |
CRANIAL NERVE DISORDER |
1 |
0.0014 |
| 26 |
CAUDA EQUINA SYNDROME |
1 |
0.0013 |
| 27 |
PROCEDURAL HYPOTENSION |
1 |
0.0012 |
| 28 |
GENITAL HYPOAESTHESIA |
1 |
0.0010 |
| 29 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
1 |
0.0009 |
| 30 |
EXTRADURAL HAEMATOMA |
1 |
0.0008 |
| 31 |
EXPOSURE DURING PREGNANCY |
44 |
0.0007 |
| 32 |
UTERINE HAEMORRHAGE |
3 |
0.0007 |
| 33 |
MYELITIS |
1 |
0.0006 |
| 34 |
OPHTHALMOPLEGIA |
1 |
0.0006 |
| 35 |
DEAFNESS NEUROSENSORY |
2 |
0.0006 |
| 36 |
CEREBELLAR INFARCTION |
1 |
0.0006 |
| 37 |
DEAFNESS BILATERAL |
1 |
0.0006 |
| 38 |
VOCAL CORD PARALYSIS |
1 |
0.0006 |
| 39 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 40 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 41 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
2 |
0.0005 |
| 42 |
OSTEOPOROTIC FRACTURE |
1 |
0.0005 |
| 43 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
3 |
0.0005 |
| 44 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 45 |
DIABETES INSIPIDUS |
1 |
0.0004 |
| 46 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 47 |
SEDATION COMPLICATION |
1 |
0.0004 |
| 48 |
AREFLEXIA |
1 |
0.0004 |
| 49 |
STRABISMUS |
1 |
0.0003 |
| 50 |
MATERNAL EXPOSURE DURING PREGNANCY |
24 |
0.0003 |
| 51 |
THERAPEUTIC PRODUCT INEFFECTIVE |
1 |
0.0003 |
| 52 |
APNOEA |
2 |
0.0003 |
| 53 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 54 |
MENINGITIS ASEPTIC |
1 |
0.0002 |
| 55 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 56 |
DISSEMINATED INTRAVASCULAR COAGULATION |
3 |
0.0002 |
| 57 |
SUBARACHNOID HAEMORRHAGE |
2 |
0.0002 |
| 58 |
STRESS CARDIOMYOPATHY |
1 |
0.0002 |
| 59 |
MYOCLONUS |
2 |
0.0002 |
| 60 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 61 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 62 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 63 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 64 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 65 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 66 |
HYSTERECTOMY |
1 |
0.0001 |
| 67 |
NEUROTOXICITY |
2 |
0.0001 |
| 68 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 69 |
HYPOTONIA |
1 |
0.0001 |
| 70 |
EYELID PTOSIS |
1 |
0.0001 |
| 71 |
CAESAREAN SECTION |
1 |
0.0001 |
| 72 |
ATAXIA |
1 |
0.0001 |
| 73 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 74 |
TACHYCARDIA |
7 |
0.0001 |
| 75 |
MYDRIASIS |
1 |
0.0001 |
| 76 |
APHONIA |
1 |
0.0001 |
| 77 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 78 |
PREMATURE BABY |
2 |
0.0001 |
| 79 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 80 |
CYANOSIS |
1 |
0.0001 |
| 81 |
PNEUMOTHORAX |
1 |
0.0001 |
| 82 |
BRADYCARDIA |
3 |
0.0001 |
| 83 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 84 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 85 |
LIVER INJURY |
1 |
0.0000 |
| 86 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 87 |
HYPOTENSION |
7 |
0.0000 |
| 88 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 89 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 90 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 91 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 92 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 93 |
URINARY RETENTION |
1 |
0.0000 |
| 94 |
HYPOXIA |
1 |
0.0000 |
| 95 |
OFF LABEL USE |
24 |
0.0000 |
| 96 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 97 |
DYSKINESIA |
1 |
0.0000 |
| 98 |
HYPERTENSION |
5 |
0.0000 |
| 99 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 100 |
COMA |
1 |
0.0000 |
| 101 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 102 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 103 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 104 |
TREMOR |
3 |
0.0000 |
| 105 |
VERTIGO |
1 |
0.0000 |
| 106 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 107 |
DRUG INEFFECTIVE |
19 |
0.0000 |
| 108 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 109 |
AGITATION |
1 |
0.0000 |
| 110 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 111 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 112 |
TREATMENT FAILURE |
1 |
0.0000 |
| 113 |
HEART RATE INCREASED |
1 |
0.0000 |
| 114 |
HAEMORRHAGE |
1 |
0.0000 |
| 115 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 116 |
ANXIETY |
2 |
0.0000 |
| 117 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 118 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 119 |
HEADACHE |
3 |
0.0000 |
| 120 |
CONSTIPATION |
1 |
0.0000 |
| 121 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 122 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 123 |
DYSPNOEA |
2 |
0.0000 |
| 124 |
NAUSEA |
2 |
0.0000 |
| 125 |
VOMITING |
1 |
0.0000 |